To explore whether other MMPs are involved in CD200 shedding, CLL cells were treated with recombinant tissue-inhibitor of metalloproteases (TIMPs), natural inhibitors of ectodomain shedding [24]. The gene discussed is CD200; the disease is B-cell chronic lymphocytic leukemia.